Disc Medicine IRON
NASDAQ IRON
$79.80 +0.43 (+0.54%)
As of: Sep 4, 2026 · 2:21 PM EDT

Disc Medicine (IRON) Assets Average (2020 - 2026)

Disc Medicine (IRON) posted quarterly Assets Average of $742.6 million for Q2 2026, up 8.07% year-over-year from $687.2 million in Q2 2025, and down 4.61% quarter-over-quarter from $778.5 million in Q1 2026.

Analysis

Disc Medicine (IRON) Assets Average (2020 - 2026) Analysis & Trends

Disc Medicine (IRON) has reported Assets Average for 7 consecutive years, with $742.6 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Assets Average rose 8.07% year-over-year to $742.6 million; the TTM figure through Jun 2026 stood at $742.6 million (up 8.07% YoY), while the FY2025 annual figure was $651.8 million, up 50.75% from the prior year.
  • Assets Average slipped to $742.6 million in Q2 2026 per IRON's latest filing, from $778.5 million in the prior quarter.
  • Across five years, Assets Average topped out at $778.5 million in Q1 2026 and bottomed at $108.3 million in Q1 2022.
  • Historically, Assets Average has averaged $430.5 million across 5 years, with a median of $406.3 million in 2023.
  • Annual changes were most pronounced in 2022 — Assets Average plunged 34.32% — and 2023, when it surged 246.76%.
  • Disc Medicine's Assets Average stood at $153.1 million in 2022, then surged by 143.11% to $372.2 million in 2023, then surged by 33.23% to $496.0 million in 2024, then soared by 44.9% to $718.7 million in 2025, then grew by 3.34% to $742.6 million in 2026.
  • Business Quant data shows IRON's Assets Average at $742.6 million in Q2 2026, $778.5 million in Q1 2026, and $718.7 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn 26.95 Bn
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn 41.30 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn 11.22 Bn
5 Revolution Medicines 44.07 Bn 44.07 Bn - 3.29 Bn
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 8.86 Bn
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn 5.34 Bn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 19.82 Bn
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn 2.09 Bn
10 Disc Medicine 3.09 Bn 3.09 Bn - 742.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 742.64 Mn
Mar 31, 2026 778.55 Mn
Dec 31, 2025 718.67 Mn
Sep 30, 2025 647.76 Mn
Jun 30, 2025 687.16 Mn
Mar 31, 2025 603.02 Mn
Dec 31, 2024 495.96 Mn
Sep 30, 2024 502.68 Mn
Jun 30, 2024 432.20 Mn
Mar 31, 2024 361.09 Mn
Dec 31, 2023 372.25 Mn
Sep 30, 2023 380.34 Mn
Jun 30, 2023 313.98 Mn
Mar 31, 2023 221.99 Mn
Dec 31, 2022 153.12 Mn
Sep 30, 2022 109.68 Mn
Jun 30, 2022 118.81 Mn
Mar 31, 2022 108.35 Mn
Dec 31, 2021 123.97 Mn
Sep 30, 2021 163.98 Mn